0.8337
price up icon1.30%   0.0107
pre-market  Pre-mercato:  .83   -0.0037   -0.44%
loading

Atossa Therapeutics Inc Azioni (ATOS) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
22.61%
6.98
9.019 7.468 7.793 7.098
Operating Income/Loss
22.61%
-6.98
-9.019 -7.468 -7.793 -7.098
Income/Loss From Continuing Operations Before Tax
24.19%
-5.878
-7.754 -6.229 -9.83 -6.281
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
24.19%
-5.878
-7.754 -6.229 -9.83 -6.281
Net Income/Loss
24.19%
-5.878
-7.754 -6.229 -9.83 -6.281
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
47,859%
125.32
-0.2624 125.79 126.62 126.62
Diluted Average Shares
125.32
- - - -
Basic Earnings Per Share
16.67%
-0.05
-0.06 -0.05 -0.08 -0.05
Diluted Earnings Per Share
-0.05
- - - -
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$78.04
price up icon 3.24%
$37.88
price up icon 2.07%
$111.24
price up icon 2.35%
$29.32
price up icon 8.31%
$110.03
price up icon 2.51%
biotechnology ONC
$304.30
price up icon 1.77%
Capitalizzazione:     |  Volume (24 ore):